<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8652029</article-id>
    <article-id pub-id-type="pmid">34734969</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab757</article-id>
    <article-id pub-id-type="publisher-id">btab757</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Creed</surname>
          <given-names>Jordan H</given-names>
        </name>
        <aff><institution>Department of Biostatistics and Bioinformatics</institution>, Tampa, FL, <country country="US">USA</country></aff>
        <xref rid="btab757-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wilson</surname>
          <given-names>Christopher M</given-names>
        </name>
        <aff><institution>Department of Biostatistics and Bioinformatics</institution>, Tampa, FL, <country country="US">USA</country></aff>
        <xref rid="btab757-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Soupir</surname>
          <given-names>Alex C</given-names>
        </name>
        <aff><institution>Department of Biostatistics and Bioinformatics</institution>, Tampa, FL, <country country="US">USA</country></aff>
        <aff><institution>Department of Tumor Biology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Colin-Leitzinger</surname>
          <given-names>Christelle M</given-names>
        </name>
        <aff><institution>Department of Cancer Epidemiology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kimmel</surname>
          <given-names>Gregory J</given-names>
        </name>
        <aff><institution>Department of Integrated Mathematical Oncology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ospina</surname>
          <given-names>Oscar E</given-names>
        </name>
        <aff><institution>Department of Biostatistics and Bioinformatics</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chakiryan</surname>
          <given-names>Nicholas H</given-names>
        </name>
        <aff><institution>Department of Genitourinary Oncology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Markowitz</surname>
          <given-names>Joseph</given-names>
        </name>
        <aff><institution>Department of Cutaneous Oncology, Moffitt Cancer Center</institution>, Tampa, FL 33612, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6620-8600</contrib-id>
        <name>
          <surname>Peres</surname>
          <given-names>Lauren C</given-names>
        </name>
        <aff><institution>Department of Cancer Epidemiology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Coghill</surname>
          <given-names>Anna</given-names>
        </name>
        <aff><institution>Department of Cancer Epidemiology</institution>, Tampa, FL, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7739-7956</contrib-id>
        <name>
          <surname>Fridley</surname>
          <given-names>Brooke L</given-names>
        </name>
        <xref rid="btab757-cor1" ref-type="corresp"/>
        <aff><institution>Department of Biostatistics and Bioinformatics</institution>, Tampa, FL, <country country="US">USA</country></aff>
        <!--fridley.lab@moffitt.org-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Mathelier</surname>
          <given-names>Anthony</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <fn id="btab757-FM1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="btab757-cor1">To whom correspondence should be addressed. <email>fridley.lab@moffitt.org</email> or <email>brooke.fridley@moffitt.org</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>01</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-11-04">
      <day>04</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>04</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <volume>37</volume>
    <issue>23</issue>
    <fpage>4584</fpage>
    <lpage>4586</lpage>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>5</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>27</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>29</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>15</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab757.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Multiplex immunofluorescence (mIF) staining combined with quantitative digital image analysis is a novel and increasingly used technique that allows for the characterization of the tumor immune microenvironment (TIME). Generally, mIF data is used to examine the abundance of immune cells in the TIME; however, this does not capture spatial patterns of immune cells throughout the TIME, a metric increasingly recognized as important for prognosis. To address this gap, we developed an R package spatialTIME that enables spatial analysis of mIF data, as well as the iTIME web application that provides a robust but simplified user interface for describing both abundance and spatial architecture of the TIME. The spatialTIME package calculates univariate and bivariate spatial statistics (e.g. Ripley’s K, Besag’s L, Macron’s M and G or nearest neighbor distance) and creates publication quality plots for spatial organization of the cells in each tissue sample. The iTIME web application allows users to statistically compare the abundance measures with patient clinical features along with visualization of the TIME for one tissue sample at a time.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>spatialTIME is implemented in R and can be downloaded from GitHub (<ext-link xlink:href="https://github.com/FridleyLab/spatialTIME" ext-link-type="uri">https://github.com/FridleyLab/spatialTIME</ext-link>) or CRAN. An extensive vignette for using spatialTIME can also be found at <ext-link xlink:href="https://cran.r-project.org/web/packages/spatialTIME/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/spatialTIME/index.html</ext-link>. iTIME is implemented within a R Shiny application and can be accessed online (<ext-link xlink:href="http://itime.moffitt.org/" ext-link-type="uri">http://itime.moffitt.org/</ext-link>), with code available on GitHub (<ext-link xlink:href="https://github.com/FridleyLab/iTIME" ext-link-type="uri">https://github.com/FridleyLab/iTIME</ext-link>).</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>H. Lee Moffitt Cancer Center &amp; Research Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100005567</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>NCI designated Comprehensive Cancer Center</institution>
          </institution-wrap>
        </funding-source>
        <award-id>P30-CA076292</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Multiplex immunofluorescence (mIF) staining combined with quantitative digital image analysis is a novel and increasingly used technique that allows for the assessment and visualization of distinct immune cell populations in the tumor immune microenvironment (TIME), as well as discrimination between tumor and stroma compartments. mIF has been recently applied to the study of many cancer types, including oropharyngeal squamous cell carcinoma (<xref rid="btab757-B13" ref-type="bibr">Tsakiroglou <italic toggle="yes">et al.</italic>, 2020</xref>), gastric cancer (<xref rid="btab757-B7" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2019</xref>) and pancreatic cancer (<xref rid="btab757-B14" ref-type="bibr">Vayrynen <italic toggle="yes">et al.</italic>, 2021</xref>). An article was also recently published outlining the opportunities and challenges in the analysis of mIF data, including approaches for spatial analysis of mIF (<xref rid="btab757-B15" ref-type="bibr">Wilson et al., 2021</xref><xref rid="btab757-B16" ref-type="bibr">b</xref>).</p>
    <p>Generally, mIF data has been used to examine the presence and abundance of immune cells in the TIME; however, this aggregate measure assumes uniform spatial patterns of immune cells throughout the tissue sample and overlooks potential spatial heterogeneity of immune marker-positive cell populations. mIF technologies also provide position data for immune cells in the TIME, thus allowing for the assessment of the spatial architecture of the TIME. Therefore, to facilitate the spatial analysis and visualization of mIF data following the preprocessing of the image data, we have developed an R package, spatialTIME and a Shiny application, iTIME.</p>
    <p>One commonly used technology for mIF data generation is the Vectra 3.0<sup>TM</sup>/Polaris<sup>TM</sup> system. Images of immune marker-stained tissues are processed within InForm (<xref rid="btab757-B5" ref-type="bibr">Gorris <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btab757-B9" ref-type="bibr">Mezheyeuski <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btab757-B10" ref-type="bibr">Mori <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btab757-B12" ref-type="bibr">Shakya <italic toggle="yes">et al.</italic>, 2020</xref>) followed by analysis with the HALO Image Analysis Platform (Indica Labs, NM). In HALO, a supervised classifier is trained to classify tissue as tumor, stroma and glass (no tissue) regions (<xref rid="btab757-B1" ref-type="bibr">Amancio <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btab757-B4" ref-type="bibr">Breiman, 2001</xref>; <xref rid="btab757-B6" ref-type="bibr">Horai <italic toggle="yes">et al.</italic>, 2019</xref>). Cell segmentation and marker quantitation is performed by compartmental examination of fluorescent intensity thresholds, with each immune marker assigned a distinct fluorescence value (<xref rid="btab757-B9" ref-type="bibr">Mezheyeuski <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btab757-B10" ref-type="bibr">Mori <italic toggle="yes">et al.</italic>, 2020</xref>). The output from this preprocessing of the mIF data is a file for each tissue sample with the locations of all detected cells and information on whether the cell is positive or negative for each of the assayed markers. In addition to the sample specific file, a summary file is also produced with the descriptive summary for each tissue sample, including the number of cells detected, the number of positive cells for each marker, percentage positive for each marker and density estimates. These summary measures can also be computed across all cells and by tumor/stroma if a tumor-associated marker is included in the assayed panel of markers. The file inputs for the spatialTIME and iTIME package follow the formats of the HALO output; however, the required file formats are general in format (i.e. cell location, indicator variable for positivity for each of the markers or prespecified combinations or ‘phenotypes’) with output from other commonly used technologies able to be easily reformatted into this general format for input into the software tools. Future updates to the package will allow for inputs directly from a variety of other technologies used in mIF studies.</p>
    <p>In spatialTIME, we have implemented a number of spatial measures of clustering including Ripley’s <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mi>K</mml:mi><mml:mi mathvariant="normal"> </mml:mi></mml:math></inline-formula> (<xref rid="btab757-B11" ref-type="bibr">Ripley, 1976</xref>), Besag’s <inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mi>L</mml:mi></mml:math></inline-formula>con’s M (<xref rid="btab757-B8" ref-type="bibr">Marcon <italic toggle="yes">et al.</italic>, 2015</xref>) and G statistic (nearest neighbor distance) using spatstat R package (<xref rid="btab757-B2" ref-type="bibr">Baddeley <italic toggle="yes">et al.</italic>, 2016</xref>). To address a unique challenge presented in mIF data generated on tissue microarrays (TMAs) whereby cores often have areas where measurements are not able to be acquired (i.e. areas with tears, folded tissue or fibrous tissue) we have implemented a permutation approach for estimating the null distribution of no clustering for which the observed clustering statistic is compared (i.e. complete spatial randomness or CSR) (<xref rid="btab757-B15" ref-type="bibr">Wilson et al., 2021a</xref>). That is, the measure to be use in downstream visualization and statistical association with clinical outcome is the degree of spatial clustering as defined as the observed value of measure—measure under assumption of CSR. Additional information on the various spatial measures can be found in <xref rid="sup1" ref-type="supplementary-material">Supplemental Materials</xref>.</p>
  </sec>
  <sec>
    <title>2 Implementation</title>
    <p>spatialTIME is available as an R package from either GitHub (<ext-link xlink:href="https://github.com/FridleyLab/spatialTIME" ext-link-type="uri">https://github.com/FridleyLab/spatialTIME</ext-link>) or CRAN (CRAN.R-project.org) and made publicly available under the MIT license. The package functionality is built upon the tidyverse principals and several of its packages along with the spatstat package. mIF experiments return two main datasets—a file with the summary-level information for the markers and individual files for each tissue sample with cell-level staining information. To combat potential confusion due to multiple samples per person, functions in spatialTIME use a custom input object called ‘mif.’ This object can be created by calling the create_mif function and requires at a minimum for users to input the summary and clinical datasets. The resulting mif object is the basis for all other functions within the package.</p>
    <p>spatialTIME provides functions for plotting mIF data for individual tissue samples and calculating univariate and bivariate measures of degree of spatial clustering and co-localization of marker-positive cells. For spatial measures of clustering, we have implemented a number of spatial measures of clustering including Ripley’s <inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:mi>K</mml:mi><mml:mi mathvariant="normal"> </mml:mi></mml:math></inline-formula> (<xref rid="btab757-B11" ref-type="bibr">Ripley, 1976</xref>), Besag’s <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:mi>L</mml:mi><mml:mi mathvariant="normal"> </mml:mi></mml:math></inline-formula> (<xref rid="btab757-B3" ref-type="bibr">Besag, 1977</xref>), Marcon’s M (<xref rid="btab757-B8" ref-type="bibr">Marcon <italic toggle="yes">et al.</italic>, 2015</xref>) and G statistic (nearest neighbor distance) using spatstat R package (<xref rid="btab757-B2" ref-type="bibr">Baddeley <italic toggle="yes">et al.</italic>, 2016</xref>). To address a unique challenge presented in mIF data generated on tissue microarrays (TMAs) whereby cores often have areas where measurements are not able to be acquired (i.e. areas with tears, folded tissue or fibrous tissue), we have implemented a permutation approach for estimating the null distribution of no clustering for which the observed clustering statistic is compared (i.e. complete spatial randomness or CSR) (<xref rid="btab757-B15" ref-type="bibr">Wilson et al., 2021a</xref>). That is, the measure to be use in downstream visualization and statistical association with clinical outcome is the degree of spatial clustering as defined as the observed value of measure—measure under assumption of CSR. The clustering functions return data frames containing spatial clustering estimates for a range of neighborhood sizes, denoted by <inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:mi>r</mml:mi></mml:math></inline-formula>, for each sample. Users also have the option of obtaining either the full empirical distribution under CSR or simply the mean of this empirical null distribution. The choice of the radius (<italic toggle="yes">r</italic>) to use for estimating the spatial measures (i.e. size of neighborhood) should be based on the scale of clustering of interest (i.e. a small value of <italic toggle="yes">r</italic> will have clustering assess for small neighborhoods while a larger value of <italic toggle="yes">r</italic> would determine the level of clustering based on large-sized neighbors). It is recommended that the association analyses of spatial measure with endpoint of interested be conducted using a few different <italic toggle="yes">r</italic> values (i.e. sensitivity analysis). Future work is planned for conducting the association of the endpoint with the entire spatial curve computed at several <italic toggle="yes">r</italic> values using functional data analysis approaches. Finally, the package allows for the creation of publication quality plots (one for each spatial sample provided) using ggplot2 which can be directly exported as a pdf. Detailed information on how to use spatialTIME can be found in the R package documentation and the vignette.</p>
    <p>The iTIME Shiny application is available at <ext-link xlink:href="http://itime.moffitt.org/" ext-link-type="uri">http://itime.moffitt.org/</ext-link> and is a point and click version with much of the functionality found in the spatialTIME package. On the ‘Importing Data’ page, users upload clinical, summary- and cell-level data in csv files and specify the variable to use for the data merge (i.e. variable that links the data across the various files). The ‘Univariate Summary’ page provides a high-level overview of the summary and clinical data files, including plots and hypothesis testing based on a beta-binomial model to compare summary marker data by clinical variable of interest. Users can customize clinical variables, color schemes and plot type for effective data visualization, including a scatter plot, boxplot, violin plot or histogram. The ‘Multivariate Summary’ page provides a heatmap and principal component plot for selected immune cell populations and provides the option to perform a clustering analysis to understand if immune cell composition of the TIME is related to clinical features. The ‘Spatial’ page displays an interactive visual of the imported cell-level data for a sample, with tumor cells displayed as triangles and stromal cells as circles, and a separate color to represent positivity for each distinct immune marker. When hovering over each cell, a text window will display the nearest neighbor distance. A plot of the measures of marker-positive immune cell spatial clustering, such as Ripley’s <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:mi>K</mml:mi></mml:math></inline-formula>, Besag’s <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:mi>L</mml:mi><mml:mo>,</mml:mo></mml:math></inline-formula> Marcon’s <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:mi>M</mml:mi></mml:math></inline-formula> and nearest neighbor distance distribution <italic toggle="yes">G</italic>, over various <inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:mi>r</mml:mi></mml:math></inline-formula> values is also generated and can be calculated specific to each immune marker. These calculations adjust for edge effects with the isotropic or translational edge (<inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mi>M</mml:mi></mml:math></inline-formula>) and reduced sample or Hanisch (<inline-formula id="IE11"><mml:math id="IM11" display="inline" overflow="scroll"><mml:mi>G</mml:mi></mml:math></inline-formula>) correction methods (<xref rid="btab757-B2" ref-type="bibr">Baddeley <italic toggle="yes">et al.</italic>, 2016</xref>), with a simulation-based envelope presented around the theoretical estimate under CSR. Currently, the iTIME application provides the theoretical distribution under the CSR assumption; however, future updates aim to also include the empirical distribution. To demonstrate the functionality of spatialTIME and iTIME, we examined two prostate tumor samples with differing TIME architecture, as presented in <xref rid="btab757-F1" ref-type="fig">Figure  1</xref>. </p>
    <fig position="float" id="btab757-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>mIF data generated from a TMA study of prostate cancer. (<bold>A</bold>) mIF image data for CD8 Positive cells measured on a prostate cancer tumor sample. (<bold>B</bold>) Plots showing CD8+ cells and locations, with illustrating a tissue sample with ‘holes’ or regions of unmeasured cells. (<bold>C</bold>) Empirical distribution of the estimate of Ripley’s <italic toggle="yes">K</italic> under CSR (N permutations = 500), with lines indicating the permuted (mean) and theoretical estimates under CSR. (<bold>D</bold>) Distribution of observed <italic toggle="yes">K</italic>, permuted estimate of <italic toggle="yes">K</italic> under CSR, and difference in these measurements (i.e. ‘degree of spatial clustering’) for the 10 core tissue samples included in spatialTIME. The degree of spatial clustering can be used in downstream association with the phenotype of interest. (<bold>E</bold>) Representation of cell locations, using the iTIME application with information in the box showing the nearest cell for each marker type. (<bold>F</bold>) Violin plot of the percent of CD8+ cells by a clinical endpoint (group A versus B) using the iTIME application</p>
      </caption>
      <graphic xlink:href="btab757f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>3 Conclusions</title>
    <p>The novel technique of mIF provides a cost-effective approach for studying the TIME in a large number of tissue samples simultaneously. This technology also provides the ability to measure not only the abundance but also the spatial location of multiple cell types within a tissue sample. The development of methods and approaches, such as those implemented in spatialTIME, that can deeply characterize both marker abundance and the spatial heterogeneity of marker-positive cells in the TIME can inform treatment approaches (e.g. immunotherapy) by providing a clearer picture of therapeutic targets in tumor tissue.</p>
    <p><italic toggle="yes">Financial Support</italic>: This work has been supported in part by the Biostatistics and Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center &amp; Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). </p>
    <p><italic toggle="yes">Conflict of Interest</italic>: Authors have no conflict of interest to declare. </p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btab757_Supplementary_Data</label>
      <media xlink:href="btab757_supplementary_data.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab757-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amancio</surname><given-names>D.R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>A systematic comparison of supervised classifiers</article-title>. <source>PLoS One</source>, <volume>9</volume>, <fpage>e94137</fpage>.<pub-id pub-id-type="pmid">24763312</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B2">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Baddeley</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <source>Spatial Point Patterns: Methodology and Applications with R</source>. <publisher-name>CRC Press</publisher-name>, <publisher-loc>Boca Raton, FL</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="btab757-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Besag</surname><given-names>J.</given-names></string-name></person-group> (<year>1977</year>) <article-title>Comments on Ripley's paper</article-title>. <source>J. R. Stat. Soc. Ser. A</source>, <volume>B39</volume>, <fpage>193</fpage>–<lpage>195</lpage>.</mixed-citation>
    </ref>
    <ref id="btab757-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breiman</surname><given-names>L.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Random forests</article-title>. <source>Mach. Learn</source>., <volume>45</volume>, <fpage>5</fpage>–<lpage>32</lpage>.</mixed-citation>
    </ref>
    <ref id="btab757-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gorris</surname><given-names>M.A.J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Eight-color multiplex immunohistochemistry for simultaneous detection of multiple immune checkpoint molecules within the tumor microenvironment</article-title>. <source>J. Immunol</source>., <volume>200</volume>, <fpage>347</fpage>–<lpage>354</lpage>.<pub-id pub-id-type="pmid">29141863</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horai</surname><given-names>Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Quantification of histopathological findings using a novel image analysis platform</article-title>. <source>J. Toxicol. Pathol</source>., <volume>32</volume>, <fpage>319</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">31719761</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>Y.K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry</article-title>. <source>Nat. Commun</source>., <volume>10</volume>, <fpage>3928</fpage>.<pub-id pub-id-type="pmid">31477692</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marcon</surname><given-names>E.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Tools to characterize point patterns: dbmss for R</article-title>. <source>J. Stat. Softw</source>., <volume>67, 1–15</volume>.</mixed-citation>
    </ref>
    <ref id="btab757-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mezheyeuski</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients</article-title>. <source>J. Pathol</source>., <volume>244</volume>, <fpage>421</fpage>–<lpage>431</lpage>.<pub-id pub-id-type="pmid">29282718</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mori</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Characterizing the tumor immune microenvironment with tyramide-based multiplex immunofluorescence</article-title>. <source>J. Mammary Gland Biol. Neoplasia</source>, <volume>25</volume>, <fpage>417</fpage>–<lpage>432</lpage>.<pub-id pub-id-type="pmid">33590360</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ripley</surname><given-names>B.D.</given-names></string-name></person-group> (<year>1976</year>) <article-title>The second-order analysis of stationary point processes</article-title>. <source>J. Appl. Probab</source>., <volume>13</volume>, <fpage>255</fpage>–<lpage>266</lpage>.</mixed-citation>
    </ref>
    <ref id="btab757-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shakya</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry</article-title>. <source>Clin. Transl. Immunol</source>., <volume>9</volume>, <fpage>e1183</fpage>.</mixed-citation>
    </ref>
    <ref id="btab757-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsakiroglou</surname><given-names>A.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma</article-title>. <source>Br. J. Cancer</source>, <volume>122</volume>, <fpage>539</fpage>–<lpage>544</lpage>.<pub-id pub-id-type="pmid">31806878</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vayrynen</surname><given-names>S.A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Composition, spatial characteristics, and prognostic significance of myeloid cell infiltration in pancreatic cancer</article-title>. <source>Clin. Cancer Res</source>., <volume>27</volume>, <fpage>1069</fpage>–<lpage>1081</lpage>.<pub-id pub-id-type="pmid">33262135</pub-id></mixed-citation>
    </ref>
    <ref id="btab757-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021a</year>) <article-title>Statistical framework for studying the spatial architecture of the tumor immune microenvironment</article-title>. <source>medRxiv</source>, <volume>2021</volume>, 2004.2027.21256104. <pub-id pub-id-type="doi">10.1101/2021.04.27.21256104</pub-id>.</mixed-citation>
    </ref>
    <ref id="btab757-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>C.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021b</year>) <article-title>Challenges and opportunities in the statistical analysis of multiplex immunofluorescence data</article-title>. <source>Cancers Basel</source>, <volume>13</volume>, <fpage>3031</fpage>.<pub-id pub-id-type="pmid">34204319</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
